Multiplex Assay Kit for Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay)

TGF-B2; TGF-Beta2; G-TSF; LAP; Cetermin; Polyergin; Latency-associated peptide; BSC-1 cell growth inhibitor; Glioblastoma-derived T-cell suppressor factor

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-98 87
EDTA plasma(n=5) 85-92 89
heparin plasma(n=5) 90-98 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 84-98% 88-96% 80-101% 92-99%
EDTA plasma(n=5) 93-101% 94-101% 88-98% 81-99%
heparin plasma(n=5) 84-101% 98-105% 94-104% 92-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:TGFb2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
international Journal of food and nutritional sciences EVALUATION OF PHYSICO-CHEMICAL PROPERTIES OF COLOSTRUM SUPPLEMENTED DAHI Ijfans: Source
J Reprod Immunol The immunomodulating effect of seminal plasma on T cells PubMed: 25799173
International Journal of Chemical Studies Studies on quality attributes of skimmed colostrum powder P-ISSN: 2349–8528
JCI Insight Angiocrine signals regulate quiescence and therapy resistance in bone metastasis Pubmed: 31292293
Mol Med Association of CASC18/miR-20a-3p/TGFB2 ceRNA axis with occult lymph node metastasis in tongue squamous cell carcinoma 34362313
Food Chem Effect of convection and microwave heating on the retention of bioactive components in human milk 34896952
Catalog No. Related products for research use of Canis familiaris; Canine (Dog) Organism species Applications (RESEARCH USE ONLY!)
RPA218Ca01 Recombinant Transforming Growth Factor Beta 2 (TGFb2) Positive Control; Immunogen; SDS-PAGE; WB.
PAA218Ca01 Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2) WB; IHC; ICC; IP.
MAA218Ca21 Monoclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2) WB; IHC; ICC; IP.
SEA218Ca ELISA Kit for Transforming Growth Factor Beta 2 (TGFb2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA218Ca Multiplex Assay Kit for Transforming Growth Factor Beta 2 (TGFb2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.